Smoking Cessation Intervention for Thoracic Patients
Lung Cancer
About this trial
This is an interventional treatment trial for Lung Cancer
Eligibility Criteria
Inclusion Criteria:
A patient is eligible if he/she:
- Is scheduled for a lung resection surgery with either a lung cancer diagnosis or a potential lung cancer diagnosis
- Smoked a cigarette in the past 2 weeks
- Is willing to make a pre-surgical quit attempt
Exclusion Criteria:
Patients will be excluded from the intervention group if they are:
- Non-English speaking
- Determined medically ineligible by their surgeon
- Suffering from psychosis or dementia
- Have been taking Varenicline for longer than three weeks
- Have been taking Bupropion (for smoking cessation purposes) for more than three weeks
- Is otherwise unable to participate in the intervention.
Sites / Locations
- Massachusetts General Hospital
Arms of the Study
Arm 1
Arm 2
No Intervention
Experimental
Control
Intervention
Usual care included physician advice to quit smoking.
Intervention participants were provided with a cognitive-behavioral 12-week program consisting of varenicline (1mg bid, with initial titration up over week 1) and smoking cessation counseling targeted to the issues of thoracic cancer patients. We offered 7 counseling sessions but were flexible in offering additional counseling when needed. Counseling was delivered by a certified Tobacco Treatment Counselor using Motivational Interviewing (MI) techniques.